🔗 Share this article

The prestigious award in Physiology or Medicine has been granted for transformative discoveries that clarify how the immune system attacks harmful pathogens while sparing the healthy tissues.

Three renowned scientists—from Japan Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—share this honor.

Their research identified unique "sentinels" within the defense system that eliminate malfunctioning immune cells capable of attacking the organism.

The discoveries are now enabling innovative treatments for autoimmune diseases and malignancies.

These winners will share a monetary award valued at 11 million Swedish kronor.

Decisive Findings

"The work has been essential for comprehending how the immune system functions and the reason we don't all suffer from serious self-attack conditions," commented the chair of the Nobel Committee.

This trio's research explain a fundamental question: How does the immune system protect us from numerous infections while leaving our own tissues unharmed?

Our immune system uses immune cells that search for indicators of infection, even pathogens and germs it has never encountered.

These defenders utilize detectors—known as receptors—that are generated randomly in countless variations.

This gives the defense network the capacity to combat a wide array of invaders, but the randomness of the process inevitably creates immune cells that can attack the body.

Protectors of the Body

Scientists earlier understood that a portion of these problematic white blood cells were eliminated in the thymus—the site where white blood cells develop.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—known as the immune system's "peacekeepers"—which travel through the body to neutralize any defenders that attack the healthy cells.

We know that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee stated, "These discoveries have established a new field of research and accelerated the creation of innovative treatments, for instance for tumors and autoimmune diseases."

In cancer, T-regs block the body from fighting the growth, so research are focused on reducing their quantity.

For autoimmune diseases, trials are exploring increasing regulatory T-cells so the body is not under attack. A comparable approach could also be effective in minimizing the risks of organ transplant failure.

Pioneering Experiments

Prof Shimon Sakaguchi, of Osaka University, performed tests on rodents that had their thymus extracted, leading to autoimmune disease.

He demonstrated that injecting defense cells from healthy animals could stop the disease—implying there was a mechanism for preventing immune cells from harming the host.

Mary Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic immune disorder in mice and humans that resulted in the identification of a genetic factor critical for how regulatory T-cells operate.

"Their pioneering research has revealed how the body's defenses is controlled by regulatory T cells, preventing it from accidentally attacking the body's own tissues," commented a leading biological science expert.

"This research is a striking illustration of how basic biological study can have far-reaching consequences for human health."